Pharmacokinetic Bioequivalence Study of Nebcinal® 150mg/3ml Administered by Aeroneb® Idehaler® Versus Tobi® 300mg/5ml Administered by Pari LC Plus® /Pulmoaid® in Patients With Cystic Fibrosis

Name: Pharmacokinetic Bioequivalence Study of Nebcinal® 150mg/3ml Administered by Aeroneb® Idehaler® Versus Tobi® 300mg/5ml Administered by Pari LC Plus® /Pulmoaid® in Patients With Cystic Fibrosis
License: Public Domain

Erempharma

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

cystic-fibrosis

cystic fibrosis

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 141033
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.